Skip to main content

Table 4 Multivariable analysis of the factors associated with HCC prevalence in cirrhotic NAFLD

From: Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a population-based study

 

Cirrhotic NAFLD

Adjusted ORa

95% CI

P value

Age > 65 years

2.35

2.05–2.70

< 0.001

Male gender

2.24

1.98–2.53

< 0.001

Non-Hispanic white

0.79

0.66–0.94

0.008

Non-Hispanic black

0.40

0.26–0.61

< 0.001

Hispanic

1.66

1.39–1.99

< 0.001

Diabetes

1.27

1.10–1.46

0.001

Hypertension

0.89

0.75–1.05

0.173

Hyperlipidemia

0.68

0.60–0.77

< 0.001

Obese

1.12

0.98–1.28

0.085

Morbid obese

0.97

0.85–1.11

0.685

Smoker

1.20

1.05–1.38

0.007

Decompensation

2.78

2.44–3.17

< 0.001

High ALT

1.97

1.74–2.24

< 0.001

  1. ALT alanine aminotransferases, CI confidence interval, HCC hepatocellular carcinoma, NAFLD non-alcoholic fatty liver disease, OR odds ratio
  2. aFactors adjusted with age, gender and white race
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us